Immunohematology Market

The global Immunohematology Market is witnessing consistent expansion as healthcare providers, blood banks, and diagnostic laboratories increasingly adopt advanced technologies for blood grouping, antibody screening, and transfusion compatibility testing. Immunohematology focuses on the interaction between red blood cell (RBC) antigens and antibodies and plays an essential role in identifying blood groups and preventing transfusion-related complications. According to Maximize Market Research, the global Immunohematology Market was valued at approximately USD 2.58 billion in 2023 and is projected to reach USD 3.40 billion by 2030, registering a CAGR of 4% during the forecast period from 2024 to 2030. Increasing investment in blood-bank infrastructure, rising demand for transfusion services, and the growing prevalence of blood-related disorders are among the major factors supporting market expansion.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 @https://www.maximizemarketresearch.com/request-sample/33950/ 

Immunohematology Market Segmentation

Based on product, the Immunohematology Market is segmented into immunohematology analyzers and immunohematology reagents. Immunohematology reagents are expected to maintain a dominant position during the forecast period because they are routinely required for blood-bank testing, antibody identification, blood grouping, and compatibility procedures. Increasing customization of reagents and the growing use of immunohematology techniques in diagnostic applications are also supporting segment growth. Analyzers, meanwhile, are benefiting from the transition from manual testing toward automated and semi-automated workflows that can improve laboratory productivity, consistency, and turnaround times.

By application, the market is categorized into cancer blood typing, antibody screening, blood-related diseases, HIV, and hepatitis. Antibody screening is an important application because it helps laboratories identify clinically significant antibodies before transfusion. Blood typing is also essential for determining donor-recipient compatibility, while immunohematology testing supports patients with conditions requiring repeated transfusions, including certain blood cancers and inherited blood disorders. By end user, the market is segmented into hospitals, academic and research institutes, diagnostics and reference laboratories, and blood banks. Blood banks represent a major demand center because of their continuous requirement for blood grouping, antibody screening, donor testing, and compatibility assessment.

Growth Drivers of the Immunohematology Market

One of the primary growth drivers is increasing investment in blood-bank infrastructure. Public and private healthcare organizations are expanding blood collection, storage, testing, and transfusion capabilities, creating demand for analyzers, reagents, software, and automated testing platforms. Growing demand for safer transfusion practices is also encouraging healthcare facilities to adopt standardized and automated testing technologies.

The increasing incidence of blood-related diseases is another important factor. Conditions such as sickle cell disease and blood cancers can increase the need for transfusion support, thereby generating demand for accurate blood typing and antibody screening. As the number of patients requiring repeated transfusions rises, healthcare institutions require reliable systems capable of identifying antibodies and supporting compatible blood selection.

Automation is further transforming the market. Automated immunohematology platforms can reduce manual intervention, improve workflow consistency, increase throughput, and support traceability of samples and results. The growing availability of connected laboratory systems is also helping blood banks integrate testing instruments with laboratory information systems and blood-bank management software. Regulatory attention toward transfusion safety and the need to reduce laboratory errors are encouraging continued investment in these technologies.

However, high costs associated with analyzers and reagents, together with shortages of skilled professionals, can restrict adoption, particularly in smaller healthcare facilities and developing markets.

Competitive Landscape

The Immunohematology Market includes established diagnostics, healthcare, laboratory technology, and blood-testing companies. Key players identified in the Maximize Market Research report include Bio-Rad Laboratories, Immucor, Grifols, BD (Becton Dickinson), Hologic, Siemens Healthcare, Thermo Fisher Scientific, Abbott, Beckman Coulter, Ortho Clinical Diagnostics, Roche Diagnostics, Merck KGaA, Cardinal Health, CSL, Danaher, MTC Invitro Diagnostics, F. Hoffmann-La Roche, and Antisel.

Competition is focused on expanding product portfolios, improving automation, increasing testing throughput, developing advanced reagents, strengthening geographic presence, and integrating instruments with laboratory information systems. Companies are also investing in technologies that can improve blood typing, antibody identification, donor screening, and data management. The increasing demand for automated and connected blood-bank workflows is encouraging manufacturers to develop integrated analyzer, reagent, software, and laboratory automation solutions.

Recent Developments

Recent developments demonstrate the industry's movement toward greater automation and improved blood-testing workflows. In June 2026, Grifols announced Evanzys IH, a next-generation automated immunohematology system designed to streamline sample processing and reduce manual intervention in transfusion medicine laboratories. The modular platform reflects the industry's increasing focus on scalable automation and laboratory efficiency.

In October 2025, Grifols began manufacturing DG Gel cards and reagent red blood cells at its new San Diego, California facility following FDA approvals. The products are used in pretransfusion patient and donor testing, and the expanded U.S. manufacturing footprint is intended to strengthen supply capabilities and respond to customer requirements.

The regulatory environment has also continued to support development of automated testing systems. In October 2025, the U.S. FDA listed the ORTHO VISION and ORTHO VISION Max analyzers as automated blood-grouping and antibody-testing systems using ID-MTS gel-card technology, with automated processing, reaction grading, interpretation, and data-management functions.

Regional Outlook

North America is projected by Maximize Market Research to maintain a leading position in the global Immunohematology Market. The region benefits from advanced healthcare infrastructure, established blood banks and diagnostic centers, early adoption of sophisticated technologies, and the availability of skilled professionals. Europe also represents an important market because of established transfusion medicine systems and regulatory emphasis on laboratory quality and patient safety. Asia Pacific is expected to provide significant growth opportunities as healthcare infrastructure develops, blood-bank networks expand, and countries such as China, India, Japan, and South Korea increase adoption of advanced diagnostic technologies.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 @https://www.maximizemarketresearch.com/request-sample/33950/ 

Future Outlook

The future of the Immunohematology Market is expected to be shaped by automation, laboratory connectivity, advanced reagent technologies, and increasing demand for accurate transfusion compatibility testing. Molecular approaches and improved blood-group characterization can complement conventional serological methods, particularly for patients with complex transfusion histories. The continued development of automated platforms is also expected to reduce manual workloads while supporting standardized testing and faster results.

With the market projected to reach USD 3.40 billion by 2030, continued investments in blood-bank infrastructure, transfusion safety, automated analyzers, reagents, and connected laboratory systems are expected to support long-term market development.

For full access to the comprehensive strategic report, visit:https://www.maximizemarketresearch.com/market-report/global-immunohematology-market/33950/ 

About Maximize Market Research

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

Contact Maximize Market Research

3rd Floor, Navale IT Park, Phase 2
Pune Bangalore Highway, Narhe,
Pune, Maharashtra 411041, India
sales@maximizemarketresearch.com
+91 96071 95908, +91 9607365656